Scientists collect samples from COVID-19 patients to unlock virus secrets

NCT ID NCT04332016

Terminated Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collected blood, urine, stool, and respiratory samples from 615 COVID-19 patients and caregivers at Bordeaux University Hospital. The goal was to build a biobank for research on the virus and disease. The study was terminated early, but the samples may still help scientists learn more about COVID-19.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this collection could help researchers better understand COVID-19 and improve future treatments or vaccines.
What could go wrong: This is a sample collection study, not a treatment trial. It was terminated early, so data may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTION VIRAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19 viral infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFECTION VIRAL

Contacts and locations

Locations

Centre Hospitalier Universitaire de Bordeaux

Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.